Supernus Pharmaceuticals Inc (SUPN) Stock Settles at $33.97: What’s Contributing to This Price Point?
Piper Sandler has recently reduced Supernus Pharmaceuticals Inc (SUPN) stock to Neutral rating, as announced on September 11, 2024, according to Finviz. Earlier, on January 3, 2023, Jefferies had resumed the stock to Buy, setting a price target of $45 for SUPN stock. Jefferies also resumed Buy rating with a price target of $44. Additionally, […]
Piper Sandler Issues Neutral Rating for Supernus Pharmaceuticals Inc (SUPN) Stock
Piper Sandler has recently reduced Supernus Pharmaceuticals Inc (SUPN) stock to Neutral rating, as announced on September 11, 2024, according to Finviz. Earlier, on January 3, 2023, Jefferies had resumed the stock to Buy, setting a price target of $45 for SUPN stock. Jefferies also resumed Buy rating with a price target of $44. Additionally, […]
Supernus Pharmaceuticals Inc (NASDAQ:SUPN) stock Posted Gross Margin of 72.95 percent in Last Year: Is Justifiable?
Jefferies raised the price target for the Supernus Pharmaceuticals Inc (NASDAQ:SUPN) stock to “a Buy”. The rating was released on January 03, 2023, according to finviz. We previously noted in another research note published on December 01, 2021 by Jefferies that resumed the stock to a Buy with a price target of $44 for SUPN […]
Supernus Pharmaceuticals Inc (SUPN) Stock: Values And Value Intersection
Jefferies raised the price target for the Supernus Pharmaceuticals Inc (NASDAQ:SUPN) stock to “a Buy”. The rating was released on January 03, 2023, according to finviz. We previously noted in another research note published on December 01, 2021 by Jefferies that resumed the stock to a Buy with a price target of $44 for SUPN […]
Why Supernus Pharmaceuticals Inc (NASDAQ:SUPN) Stock up 1.76% in Last Week?
Jefferies raised the price target for the Supernus Pharmaceuticals Inc (NASDAQ:SUPN) stock to “a Buy”. The rating was released on January 03, 2023, according to finviz. We previously noted in another research note published on December 01, 2021 by Jefferies that resumed the stock to a Buy with a price target of $44 for SUPN […]
What is happening with Supernus Pharmaceuticals Inc (SUPN) Stock?
Jefferies raised the price target for the Supernus Pharmaceuticals Inc (NASDAQ:SUPN) stock to “a Buy”. The rating was released on January 03, 2023, according to finviz. We previously noted in another research note published on December 01, 2021 by Jefferies that resumed the stock to a Buy with a price target of $44 for SUPN […]
